Mucopolysaccharidosis Type 6 (MPS VI, Maroteaux-Lamy Syndrome)Symptoms, Doctors, Treatments, Advances & More
Learn About Mucopolysaccharidosis Type 6 (MPS VI, Maroteaux-Lamy Syndrome)
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
UCSF Benioff Children's Hospital Oakland
Paul Harmatz is a Pediatric Gastroenterologist practicing medicine in Oakland, California. Dr. Harmatz is rated as an Elite provider by MediFind in the treatment of Mucopolysaccharidosis Type 6 (MPS VI, Maroteaux-Lamy Syndrome). He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Mucopolysaccharidoses (MPS), Mucopolysaccharidosis Type 6 (MPS VI, Maroteaux-Lamy Syndrome), Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), and Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome). Dr. Harmatz is board certified in American Board Of Pediatrics.
Rita Ferla practices practicing medicine in Naples, Italy. Ms. Ferla is rated as an Elite expert by MediFind in the treatment of Mucopolysaccharidosis Type 6 (MPS VI, Maroteaux-Lamy Syndrome). She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Mucopolysaccharidosis Type 6 (MPS VI, Maroteaux-Lamy Syndrome), Mucopolysaccharidoses (MPS), Retinopathy Pigmentary Mental Retardation, and Late-Onset Retinal Degeneration.
Alberto Auricchio practices practicing medicine in Naples, Italy. Mr. Auricchio is rated as an Elite expert by MediFind in the treatment of Mucopolysaccharidosis Type 6 (MPS VI, Maroteaux-Lamy Syndrome). He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Mucopolysaccharidosis Type 6 (MPS VI, Maroteaux-Lamy Syndrome), Gyrate Atrophy of the Choroid and Retina, Retinopathy Pigmentary Mental Retardation, and Usher Syndrome.
Summary: This is an international prospective and retrospective registry of patients with Lysosomal Storage Diseases (LSDs) to understand the natural history of the disease and the outcomes of fetal therapies, with the overall goal of improving the prenatal management of patients with LSDs.
Summary: The goal of this observational study is to characterize the epidemiology and natural history of MPS diseases by building a retrospective and prospective collection of extensive phenotypic data from French MPS patients.